[Treatment of coronary bifurcation lesions]

Enrico Romagnoli1, Fabrizio Clementi, Giuseppe G L Biondi-Zoccai

  • 1Unità di Cardiologia Interventistica, Ospedale San Raffaele, Milano.

Giornale Italiano Di Cardiologia (2006)
|October 24, 2008
PubMed

Insights

Treating coronary bifurcation lesions remains complex, despite advances. Current strategies, including provisional stenting, still face challenges with restenosis and adverse events, necessitating optimized approaches.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research

Context:

  • Coronary bifurcation lesions represent 15-20% of percutaneous coronary interventions.
  • Despite advancements in techniques and drug-eluting stents, these lesions are associated with higher complication rates, reinterventions, and adverse clinical events.

Purpose:

  • To review the anatomical characteristics of coronary bifurcations.
  • To discuss the technical difficulties encountered during percutaneous treatment.
  • To explore optimal strategic approaches for managing these complex lesions.

Summary:

  • Percutaneous treatment of coronary bifurcations presents significant technical and clinical challenges.
  • While drug-eluting stents have reduced restenosis, they haven't fundamentally altered treatment strategies or improved long-term outcomes.
  • The provisional stenting technique remains the preferred approach, but high rates of side branch ostium restenosis persist.

Impact:

  • Highlights the persistent challenges in coronary bifurcation lesion treatment.
  • Underscores the need for improved strategies beyond current stenting techniques.
  • Informs future research and clinical practice for better patient outcomes in complex coronary interventions.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...